INTRODUCTION
Myasthenia gravis is an uncommon disease characterised by a fluctuating course and occasional spontaneous remissions. The association between this disease and thymic pathology has long been recognised. 1 Since the results of thymectomies were first reported, over forty years ago,2 surgery has played an increasingly important role in its management. While there is general agreement about the potential benefits of operative intervention,3 there has been considerable debate about the indications for timing of surgery, and also the prediction of its results. The high morbidity and mortality quoted in earlier series,2 4 together with reports that young women with mild disease of short duration were more likely to do better,5 tended to influence patient selection. As a result, a fair assessment of thymectomy was not possible. More recent series have broadened patient selection considerably,6 7 (Table II) . There was no difference in benefit between the sexes. Five achieved no benefit or were worse off following surgery (24%). There were no post-operative deaths or deaths at a later period. Five of the group of 21 patients required ventilatory support for periods ranging from 5 days to one month post-operatively. The most common pathological findings were hyperplasia (7 cases), thymoma (6 cases) and normal glands (8 cases). There appeared to be no correlation between thymic pathology and the surgical result. There was no difference in age between those who benefited from thymectomy and those who did not (mean 34.0 and 33.2 years respectively). There was no difference between the median duration of symptoms (benefit 19 months, no benefit 18 months) or in the sex distribution (benefit 79% female, 71 % male). (Table III) . (1) G = generalised, B = bulbar. 
DISCUSSION
When Blalock reported the results of the first series of thymectomies for myasthenia gravis 40 years ago, he concluded that, while the procedure was probably beneficial, it was not possible to predict the outcome of surgery.2
Since then, there has been unanimous agreement that thymectomy can be of benefit but considerable disagreement on the prediction of results. Five years after this first series, Keynes reported that a long history prior to surgery was prejudicial to recovery.9 He also made the important observation that, due to the fluctuating course of the disease, it was difficult to assess the results. In an extensive review of Keynes's work, Simpson in 1958 reaffirmed the conclusion that those most likely to benefit from surgery were those with symptoms of less than five years' duration.' Apart from this, no other significant factors were observed which could help predict the outcome. While there are still those who feel that young women6, 11 and those patients having a short history6 10 constitute favourable groupings, there is considerable evidence from others that there are no reliable predictors of a favourable result.3,7 Attempts have been made to correlate thymic pathology9 14 and acetylcholine receptor antibody titres13 14 with the results of surgery. However, recent reports suggest that, with the exception of thymomas which may indicate a poor prognosis, pathological findings6 7 15, 16 and reduction in acetylcholine receptor antibody titres"1 12, 16 are not important factors in the outcome following thymectomy.
From this series we can make several observations. With 76% obtaining benefit from thymectomy there can be no doubt that it is a worthwhile procedure. There was no sex difference between those who improved following surgery and those who did not, but it is worth noting that all those who obtained a complete remission were female. We could find no evidence that age or short duration of symptoms were favourable factors, in fact one patient with symptoms for 35 years benefited from surgery. Neither did thfymic histology seem to correlate with the eventual outcome, two patients with thymomas responding well to surgery. That there is a very definite morbidity associated with thymectomy in those suffering from myasthenia gravis'7 is borne out by five out of our group of 21 requiring post-operative ventilatory support. Unlike some of the earlier series which reported a high mortality,2'4 we had no deaths in the immediate postoperative period or later during the period of this review. In conclusion we feel that thymectomy is a relatively safe and effective procedure in the management of myasthenia gravis. From our experience there are no factors which enable one to predict the outcome of surgery. For this reason we feel that surgery should be offered to all except those with the mildest disease.
